FEB 23, 2017 7:30 AM PST

KEYNOTE: Towards a new era of precision medicine in psychiatry: Using genetic algorithms to optimize medication outcome

Speaker
  • Head of the Pharmacogenetics Research Clinic at the Campbell Family Mental Health Research Institute at CAMH, and Associate Professor in the Department of Psychiatry at the University of Toro
    BIOGRAPHY

Abstract

Psychiatric disorders are among the leading causes of disability worldwide. One fifth of the population will suffer from a psychiatric disorder in their lifetime. Antipsychotic and antidepressant drugs remain the cornerstone of treatment in schizophrenia and mood disorders. However, more than 50% of patients do not respond well to their initial treatment and much time is often spent until the right medication is found for the right patient.  In addition, some develop serious side-effects that cause them to discontinue the medication. Thus, predictive tools would be of enormous help to optimize and personalize medication treatment.

Genomics offer a tremendous opportunity to personalize medication treatment by use of preemptive genotyping selected genes known to be involved in drug metabolism, neurotransmission and occurrence of side effects. Over the past decade, evidence has emerged that assessing gene variants for drug metabolizing enzymes such CYP2D6 or CYP2C19   can be used to improve treatment with antidepressant and antipsychotics. In addition, various gene variants have been identified involved in psychotropic medication induced side effects such ads for carbamazepine-induced Steven-Johnsons Syndrome or antipsychotic-induced weight gain.

The presentation will review current recommendations provided by expert panels such as the Clinical Pharmacogenomics Implementation Consortium (CPIC) and regulatory agencies (e.g., FDA). Data from our own research studies in Toronto including more than 7,000 patients will be presented showing acceptance and benefits of genetic testing in clinical practice. In addition, implementation strategies and cost-benefits will be reviewed, and commercially available test kits will be critically discussed.    

 

Learning Objective 1:  Understanding principles of how genetics influences response and side effects in psychopharmacology      

 

Learning Objective 2:  Application of pharmacogenetics in clinical practice 


Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
SEP 22, 2022 9:00 AM PDT
SEP 22, 2022 9:00 AM PDT
Date: September 22, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Optimizing platforms for surgical specimen collection and deep human phenotyping was used to enhance protein biomarke...
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
AUG 16, 2022 11:00 AM PDT
AUG 16, 2022 11:00 AM PDT
Date: August 16, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Understanding genomic variation in the context of cancer is paramount to identifying disease drivers and informing pers...
AUG 24, 2022 7:00 AM PDT
AUG 24, 2022 7:00 AM PDT
Date: August 24, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) Light field microscopy was first introduced in 2006, and allows users to capture the 4D light field within the microsco...
NOV 16, 2022 7:00 PM PST
C.E. CREDITS
NOV 16, 2022 7:00 PM PST
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
FEB 23, 2017 7:30 AM PST

KEYNOTE: Towards a new era of precision medicine in psychiatry: Using genetic algorithms to optimize medication outcome



Show Resources
Loading Comments...
Show Resources
Attendees